TITLE

Sunesis Pharmaceuticals, Inc., SWOT Analysis

PUB. DATE
October 2013
SOURCE
Sunesis Pharmaceuticals, Inc SWOT Analysis;Oct2013, p1
SOURCE TYPE
SWOT Analysis
DOC. TYPE
Article
ABSTRACT
A business analysis of Sunesis Pharmaceuticals Inc., a firm provides oncology therapeutics for treatment of solid and hematologic cancers is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to the company. Strengths include the completion of the interim analysis of Vosaroxin. Weaknesses include lack of marketed products. Opportunities for improvement include the development in oncology market. Threats to the company include lengthy clinical trials.
ACCESSION #
91986449

 

Related Articles

  • SWOT Analysis.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;Aug2008, p1 

    A company profile of Sunesis Pharmaceuticals Inc., a biopharmaceutical company dedicated to developing and providing novel, small molecule therapeutics for oncology and other unmet medical needs, is presented. An overview of the company is given, along with key facts including contact...

  • Sunesis Pharmaceuticals, Inc. SWOT Analysis.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;Aug2012, p1 

    A business analysis of Sunesis Pharmaceuticals Inc., a company which focuses on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, is provided, focusing on its strengths, weaknesses, opportunities for improvement and threats to...

  • SWOT Analysis.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;May2007, p5 

    A business analysis of Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, is provided, focusing on its strengths, weaknesses,...

  • Company Overview.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;May2007, p4 

    An overview of Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, is presented. Data is included on revenues generated in fiscal year...

  • Sunesis Pharmaceuticals, Inc SWOT Analysis.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;Oct2007, p1 

    A company profile of Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, is presented. An overview of the company is given, along with...

  • Key Facts.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;Oct2007, p4 

    Key facts about Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, are presented. Address and contact information is given, as well as...

  • Sunesis Pharmaceuticals, Inc SWOT Analysis.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;May2007, p1 

    A company profile of Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, is presented. An overview of the company is given, along with...

  • Key Facts.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;May2007, p4 

    Key facts about Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, are presented. Address and contact information is given, as well as...

  • Company Overview.  // Sunesis Pharmaceuticals, Inc SWOT Analysis;Oct2007, p4 

    An overview of Sunesis Pharmaceuticals Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel, small molecule therapeutics for the use in oncology and other unmet medical needs, is presented. Data is included on revenues generated in fiscal year...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics